Reviewing the Utility of EUS FNA to Advance Precision Medicine in Pancreatic Cancer

Volume: 10, Issue: 2, Pages: 35 - 35
Published: Jan 27, 2018
Abstract
Advanced pancreatic cancer (PC) is an aggressive malignancy with few effective therapeutic options. While the evolution of precision medicine in recent decades has changed the treatment landscape in many cancers, at present no targeted therapies are used in the routine management of PC. Only a minority of patients with PC present with surgically resectable disease, and in the remainder obtaining high quality biopsy material for both diagnosis...
Paper Details
Title
Reviewing the Utility of EUS FNA to Advance Precision Medicine in Pancreatic Cancer
Published Date
Jan 27, 2018
Journal
Volume
10
Issue
2
Pages
35 - 35
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.